TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
Biobank AS
Closing information (x1000 EUR)
Closing information | 2023/12 | 2022/12 | 2021/12 |
Turnover |
1,239
|
1,381
|
1,296 |
Financial expenses |
2
|
3
![]() |
3 |
Earnings before taxes |
172
|
35
|
93 |
Total assets |
1,327
|
1,375
|
1,494 |
Current assets |
1,161
|
1,148
|
1,221 |
Current liabilities |
196
|
237
|
262 |
Equity capital |
910
|
828
|
844 |
- share capital |
27
|
28
|
30 |
Financial ratios
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Solvency |
68.6%
|
60.2%
|
56.5% |
Turnover per employee | |||
Profit as a percentage of turnover |
13.9%
|
2.5%
|
7.2% |
Return on assets (ROA) |
13.1%
|
2.8%
|
6.4% |
Current ratio |
592.3%
|
484.4%
|
466.0% |
Return on equity (ROE) |
18.9%
|
4.2%
|
11.0% |
Change turnover |
-54
|
154
|
-144 |
Change turnover % |
-4%
|
13%
|
-10% |
Chg. No. of employees | |||
Chg. No. of employees % |
Total value of public sale
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.